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A B ST R AC T 
 
 
Anorexia nervosa (AN) is a psychiatric disorder that predominantly affects 
young women and is characterized by low caloric intake and a major 
dissatisfaction with one’s body image. It is often overlooked and, while 
patients and family seek medical help, emaciation and nutritional 
misbalances may become extreme and potentially life threatening. Among 
the many somatic complications, an accumulation of early endocrine 
adaptations occurs, leading to functional amenorrhea and impaired 
reproduction as a result of dysfunction of the hypothalamic-pituitary-ovarian 
axis. Even though these conditions are reversible, long-term consequences 
may affect the fertility of women with AN and can lead to maternal and fetal 
complications during pregnancy and birth. This review presents the clinical 
particularities of reproduction in the context of AN, along with the possible 
pathophysiological mechanisms involved.   
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Anorexia nervosa (AN) is an eating disorder that 
consists of abnormally low body weight, a distorted 
perception of body image, and a fear of gaining weight [1]. 
Patients suffering from this condition have a major 
dissatisfaction with their body shape or size, and either 
perceive themselves as being fat despite extreme 
starvation, or become aware of their low weight but are in 
denial of its seriousness. The patients have a negative 
energy balance as a result of strict dieting or intense and 
extreme physical exercise [2].  
Semantically, anorexia nervosa means the “neurotic 
loss of appetite,” the condition being described as long as 
several centuries ago [3,4]. However, the diagnostic 
criteria for AN have changed substantially over time, being 
revised and redefined with each edition of the Diagnostic 
and Statistical Manual of Mental Disorders (DSM). 
Although in current medical practice, the DSM-IV criteria 
are better known and applied, the most recent definition of 
AN dates to 2013 when DSM-5 removed the condition for 
amenorrhea from the diagnostic criteria, along with any 
threshold value for defining “low weight” [3,5]. Despite 
the fact that amenorrhea is common among patients 
suffering from AN, its assumption as a necessary element 
in the diagnosis algorithm of AN was limiting, as it did not 
take into consideration pre-pubertal or post-menopausal 
females, or females under contraceptive treatment. As a 
further matter, the DSM-IV definition was not inclusive of 
male patients, as their gonadal axis status was not taken 
into consideration [6,7].   
Even though the actual diagnosis of AN is based solely 
on clinical judgment, the DSM-5 task force recommended 
using body mass index (BMI) for adults or corresponding 
BMI percentiles for adolescents in order to classify disease 
severity into four categories: mild (BMI>17kg/m2), 
moderate (BMI 16-16.99kg/m2), severe (BMI 15-
15.99kg/m2), and extreme (BMI<15kg/m2). In addition, 
the disease is given two subtypes: restrictive AN and 
binge-eating/purging type, depending on patients’ 
behavior and their attitudes towards dieting, exercising, or 
purging [5]. Last, the same task force defined atypical 
anorexia nervosa as a distinct eating disorder that 
encompasses all the features of typical AN, except low 
weight.  
As expected, the more lenient definition of AN has led 
to an increase in its lifetime prevalence [8-10], which now 
reaches 4% [11,12]. It can affect both sexes, but is much 
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more common among females, with a male-to-female ratio 
estimated to be 1:10. Even though it may occur at any age, 
its highest incidence occurs before the age of 20 years 
[5,13]. Its lifetime prognosis is good, although on a somatic 
level, the complications from emaciation, poor nutrition, or 
purging behavior may have long term effects. In addition, 
from a psychiatric perspective, relapses are possible, as 
well as association with other psychiatric diseases such as 
depression, anxiety disorders, social phobia, or obsessive-
compulsive disorder [14]. According to several studies, 
approximately one fifth of all death causes of anorexic 
patients lies in suicide, which, along with medical disorders 
of the disease itself, raise the base mortality rate to 5% per 
decade [15,16].  
Little is known about the etiology and triggers of AN, 
but genetic, environmental, and neurobiological factors 
seem to be involved [17]. Among the many metabolic 
complications, AN is characterized by an accumulation of 
endocrine adaptations such as acquired growth hormone 
(GH) resistance and subsequent low insulin-like growth 
factor (IGF1), chronic adrenal stimulation, euthyroid sick 
syndrome which, along with extreme starvation, is 
responsible for a further decrease in energy expenditure 
[3,18] and hypogonadotropic hypogonadism which leads 
to low trabecular score, impaired bone mineral density 
(BMD) [19], and functional amenorrhea. Considering that 
affected women are less likely to start a family and have 
children [20], this review addresses the issue of fertility and 
reproduction of females with a lifetime diagnosis of AN.  
The aim of this review is, first, to provide an in-depth 
overview of the recent information regarding clinical and 
biological anomalies of reproduction in AN female 
subjects. A second objective is to define better clinical 
approaches regarding menstrual disturbances and 
pregnancy management in AN patients. Finally, we aim to 
identify less-explored pathophysiological mechanisms and 
potentially open new perspectives for further research in 
the near future.        
A comprehensive search of the current literature on 
menstrual history, fertility and pregnancy, and birth 
outcomes related to AN was conducted via PubMed 
database in order to identify relevant studies published up 
to December 2019. We also included terminology for some 
of the biological and pathophysiological underpinnings of 
these clinical outcomes. For this purpose, we used a series 
of logical combinations of keywords and Medical Subject 
Headings (MeSH) terms, as follows: “anorexia nervosa”, 
“reproduction”, “fertility”, “pregnancy”, “kisspeptin”, 
“leptin”, “gonadotrophs”, “neurotransmitters,” and 
restriction to English language articles was made. No 
restriction was made on date or study type, but priority was 
given to recent clinical trials, although several relevant 
reviews or animal studies were included. An initial search 
identified 102 articles. We removed duplicates and 
considered for critical review only full text articles relevant 
to the topic, with 53 remaining articles included in our final 
analyses. To these, information from 14 additional articles 
or books was reviewed when documenting the 
epidemiology and general traits of anorexia nervosa. The 
present article is structured in two parts: in the first part we 
deal with the clinical aspects of reproduction in AN, and in 
the second part the mechanisms underlining them. 
Discussions 
Reproduction in the setting of AN 
Optimal reproduction requires a mature and intact 
hypothalamic-pituitary-ovarian-axis, which in conditions 
of energy depletion and chronic stress can be difficult to 
achieve. Clinical studies investigating the effects of 
malnutrition and famine have shown that good 
reproductive capacity depends on adequate nutritional 
intake [21]. Furthermore, beyond the multiple somatic 
dysfunctions of anorexia, the sparse emotional availability 
of such patients leads to decreased libido and a rejection of 
sexual activity [22], which may also alter the odds of 
procreation. In this paper, we focus on clinical aspects that 
govern the reproduction and fertility of anorexic females. 
Menstrual disturbances in anorexic females 
From an evolutionary perspective, reproduction and 
growth are the first physiological processes to be sacrificed 
under conditions of intense stress that threaten survival. If 
anovulation is key to preservation, its clinical appearance 
can embrace different forms, from delayed or arrested 
puberty to menstrual irregularities or infertility, depending 
on the time of onset of AN, its duration, and severity. 
Consequently, females with AN can experience a wide 
range of menstrual disorders, such as anovulatory 
eumenorrhea, shortened or prolonged menses due to 
defects of follicular or luteal phases, premenstrual spotting, 
oligomenorrhea, or even amenorrhea [23].  
Menarche is among the latter events in pubertal 
development and it follows thelarche and the rise of 
gonadal hormones by approximately 1.5-2 years. Evidence 
suggests that a weight loss of merely 10 to 15% from the 
normal weight-for-height can delay the age of menarche 
and sexual development [22,24]. A study conducted on a 
relatively large cohort of women (n=841) showed that 10% 
of anorexic females experienced primary amenorrhea, 
defined as a lack of menarche until the age of sixteen [24]. 
This same study emphasized the importance of age at onset 
of disease, because the vast majority of patients with 
primary amenorrhea experienced AN prior to the menarche 
and also reached the personal weight nadir at a younger age 
than patients with physiological menarche.  
The same degree of weight loss of 10-15% from the 
normal weight seems to lead to a cessation of menstrual 
cycle in post-pubertal women as well [22,25]. So far, there 
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are no clear predictive factors for the resumption of 
menses. In 2013, Dempfle et al. showed that only half of 
amenorrheic patients resumed menses within one year 
from diagnosis, at a mean BMI of 19kg/m2 [26]. This 
finding is consistent with previous data showing that by 
one year from diagnosis, two thirds of anorexic females 
resumed menses, when they have reached either 90% of 
standard body weight for age and height, or were, in 
general, 2 kilos above the weight at which they stopped 
menstruating [27]. Other predictors for resumption of 
menses are body fat percentage, intensity of exercise, or 
even IGF1 levels (27–29) but, despite intense nutritional 
intervention, a large number of patients remained 
amenorrheic, highlighting that stress, anxiety, or 
psychological factors may play a role [8,13]. 
Fertility and fecundity  
Fecundity is defined as the biological capacity to 
reproduce and is often indirectly assessed in 
epidemiological studies by measuring the rate of births, an 
index of fertility [30]. Power et al. showed that the fertility 
rate of patients with AN (defined as the mean number of 
children compared with that of the general population) is 
distinctly lower [31]. Moreover, results of a large 
longitudinal study describing the long-term outcome of AN 
found that only a quarter of anorexic patients became 
mothers at the time of follow-up, which is 2 to 3 times less 
than that of the general population [32].  
Due to their menstrual impairment, females with AN 
are generally considered less fertile, and are, indeed, more 
likely to seek medical help regarding a fertility problem, 
but ultimately only women with both anorexia and bulimia 
nervosa are more likely to actually undergo treatment for 
infertility [33]. Eating disorders (ED) in general make 
individuals prone to infertility due to disruption of the 
hypothalamic-pituitary-ovarian axis and subsequent 
ovulatory dysfunction [34], but conflicting data exist [35] 
and clarifying studies are required.  
It is clear that patients with ED are overrepresented in 
assisted human reproduction clinics [36] and, in 2014, 
Bruneau et al. reported that 8% of females visiting an 
infertility clinic met criteria for past AN, a rate higher than 
the prevalence in the general population [37]. They have a 
lower BMI than infertile patients without a lifetime 
diagnosis of AN and a higher level of anxiety [37]. Often 
their pathology is not recognized by trained infertility 
specialists [38], and even though precise guidelines for ED 
management regarding fertility treatment are missing, 
current recommendations involve inducing ovulation only 
in women with a minimum BMI of 18.5kg/m2 [23].  
Nevertheless, it is still questionable to what extent their 
poorer fertility is due to ovulatory dysfunction. In the 
AVON Longitudinal Study of Parents and Children, 40% 
of females with AN admitted that their current pregnancy 
was unplanned, probably due to the misbelief that they 
were infertile [33]. Hence, it is more likely that anorexic 
females lack a stable partner and have ambivalent feelings 
towards pregnancy and motherhood, as reported in several 
studies [33,37,39], which may explain their lower fertility 
rate reported in literature. 
Pregnancy and birth outcomes 
Pregnant women with lifetime ED are at a higher risk 
to develop fetal and maternal complications and have 
poorer birth outcomes [40]. However, the evidence is 
conflicting, and while some studies note an increased risk 
for miscarriages, inadequate maternal weight gain during 
pregnancy, cesarean delivery, and small-for-gestational-
age babies, or fetal distress [38,41], other studies suggest 
that the prognosis for pregnancy and birth for women with 
lifetime AN is approximately the same as for healthy 
subjects [42]. Watson et al. found an increased rate of 
cesarean delivery among patients ever having suffered 
from any ED [40], consistent with previous findings of 
Pasternak et al. [43].  Moreover, the birthweights tend to 
be slightly lower for children born to mothers who had AN 
[42-44], but, according to Micalli et al., this difference 
seems to be correlated with lower pre-gestational maternal 
BMI rather than with the disease itself [44]. Also, while 
women with a former diagnosis of AN have a lower, yet, 
within normal range BMI, their weight gain during 
pregnancy is actually higher than normally expected [41]. 
Regarding prematurity, AN alone does not predispose to a 
higher risk [40] than any other ED or to combined forms of 
AN and bulimia [41,43]. 
Going beyond the clinic  
The biological mechanisms underlying the 
aforementioned clinical manifestations of AN remain 
uncertain. The literature on the role of neurotransmitters 
and hormones and their mechanisms of action is still 
limited, but recently, scientific evidence has yielded new 
insights. In the following sections, we detail some of the 
pathophysiological aspects relating reproductive 
anomalies to brain function. 
Hypothalamic-pituitary-ovarian axis 
The physiology of human reproduction in females is 
based on three functioning systems: the anterior 
hypothalamus where gonadotropin-releasing hormone 
(GnRH) is synthesized and secreted from the arcuate 
nucleus, the anterior pituitary that responds to GnRH by 
secreting follicle stimulating (FSH) and luteinizing 
hormone (LH), and the ovaries, that respond to the trophic 
action of the so-called gonadotrophins (FSH and LH) by 
producing estrogens through the menstrual cycle, 
progesterone in the luteal phase, as well as oocytes 
necessary for fertilization. The system auto-regulates by 
using a feedback mechanism, as estrogens signal at a 
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central level the availability of peripheral gonadal 
hormones and, thus, modulate GnRH secretion [45,46]. In 
sexually mature individuals, the release of GnRH follows 
a pulsatile pattern, generally every 60 to 90 minutes, 
leading to a rhythmic secretion of gonadotrophins [46]. 
Several studies have demonstrated that acute AN 
disrupts the normal functioning of the reproductive axis, 
and the pulsatile secretion of LH regresses to a prepubertal 
and immature pattern [18], especially when caloric 
restriction falls under 30kcal/kg/day [23]. As a result, 
GnRH suppression occurs, which then is manifested as 
hypothalamic amenorrhea [47]. On the one hand, GnRH 
suppression is directly responsible for the changes in LH 
amplitude and frequency pulses, which compromise the 
secretion of progesterone in thecal cells in the ovary. On 
the other hand, it lowers the secretion of FSH which alters 
the selection of the dominant follicle and thus diminishes 
the synthesis and secretion of estrogens [46]. Therefore, 
lower LH, FSH, and estradiol (E2) characterize the 
hormonal profile of anorexic patients [48] and positive 
correlations exist between the plasmatic level of these 
hormones and patient’s BMI [49]. However, surprising 
data recently emerged showing that weight-recovered 
anorexic patients that were still amenorrheic had higher 
levels of sex hormones and gonadotrophins and better 
responses to pulsatile GnRH therapy than other women 
suffering from hypothalamic amenorrhea [50]. 
Last, the disproportioned sex distribution of AN 
predominating in women raises the hypothesis that, 
alongside its contribution to reproductive impairment, 
estradiol may also play an etio-pathogenic role, perhaps 
affecting satiety control and orexigenic peptides 
modulation [18]. 
Leptin 
Leptin is an anorexigenic hormone secreted in adipose 
tissue, responsible for centrally signaling satiety and 
available energy deposits. It is now widely accepted that 
leptin modulates the activity of the reproductive axis by 
suppressing it in the case of an inadequate fat reservoir 
[51]. It plays a central role in metabolic control of fertility 
as it stimulates the hypothalamic expression of GnRH [52], 
even though specific leptin receptors in GnRH neurons are 
lacking. Compelling evidence suggests that kisspeptin is at 
the interplay between leptin and GnRH, and mRNA 
encoding leptin receptors have been found in the Kiss1 
positive neurons of the arcuate nucleus [53]. Its connection 
to the hypothalamic-pituitary-ovarian axis is also shown by 
variations of its plasmatic concentrations during the 
menstrual cycle, as its level is slightly increased during the 
luteal phase and lower during the early follicular phase 
[52].  
Furthermore, low levels of leptin, suggesting reduced 
fat mass, are associated with sexual immaturity [52] as it 
accompanies low LH secretion [23]. In line with this, in 
AN, as in all pathologies involving low fat mass, its level 
drops [54,55]. Interestingly and contrary to the general 
belief that leptin is a starvation hormone, in one study 
leptin was positively associated with appetite, suggesting 
that in individuals with AN, body weight regulation may 
be altered [55]. Experimental administration of exogenous 
leptin prevents stress-induced hyperactivity in anorexic 
patients, and even though leptin therapy is a potential 
regulator for resumption of menses, its use in AN is not 
feasible, as it decreases both appetite and adipose tissue 
[18]. 
Kisspeptin  
Initially described two decades ago as a metastatic-
suppressor factor of melanoma cells [56], after the 
identification of its receptor, kiss1R, kisspeptin was 
defined as a neuropeptide and assigned several endocrine 
and metabolic functions [57]. It is expressed in a variety of 
peripheral tissues within the gonads, placenta, small 
intestine, and pancreas, but its main site of action is located 
in the brain, specifically within hypothalamic neurons 
located in the arcuate nucleus (ARC) and the preoptic area, 
which corresponds to the rostral periventricular region of 
the third ventricle (RP3V) in rodents [45]. It plays a major 
role in reproduction as it facilitates the feedback 
mechanisms of the hypothalamic-pituitary-ovarian axis 
and triggers puberty initiation [58]. GnRH neurons lack 
requisite receptors for estradiol, but seem to have an 
affinity for kisspeptin, which mediates the dual feedback 
of the sexual hormones: negative feedback through ARC 
which is necessary for GnRH pulse generation, and 
positive feedback through RP3V which is necessary for LH 
pre-ovulatory surge [45]. Moreover, Millar et al. found that 
while kisspeptin may not be important in maintaining basal 
LH levels, it is, nevertheless, crucial for its pre-ovulatory 
stimulation [59].  
Other than its role in reproductive function, kisspeptin 
also seems involved in inducing adequate reproductive 
behavior, as observed in animal studies [60], as well as 
modulating reactions to fear [61] and anxiety [62]. Outside 
the brain, among its increasingly identified roles, 
kisspeptin is involved in the implantation of the embryo, in 
the decidualisation of the endometrium and, by binding to 
its placental receptors, in the angiogenesis of the placenta 
[63]. As a further matter, by exploring its actions on 
metabolism, Tolson et al. showed that kisspeptin is 
involved in maintaining glucose homeostasis and weight 
[64]. 
The scientific evidence of kisspeptin variation in 
anorexia cases is yet sparse. However, given that food 
deprivation suppresses hypothalamic kiss1 mRNA [65], 
and that experimental administration of kisspeptin in 
women with functional hypothalamic amenorrhea 
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increased LH pulses [46], this neuropeptide may serve 
important functions. The few data available have shown a 
negative correlation between kisspeptin and intensity of 
exercise [66,67], but have failed to establish a connection 
with anxiety in AN patients [67]. An interesting finding 
reported by Bacopoulou is that menstruating females with 
atypical AN have higher levels of kisspeptin when 
compared to amenorrheic anorexic patients [49], 
suggesting that kisspeptin rises in order to keep a normal 
gonadal function.  
Others  
Many other neurotransmitters participate in the 
dynamics of reproductive regulation. To name a few, 
ghrelin, which is synthetized in the digestive system, is one 
of the most potent orexigenic hormones. It inhibits GnRH 
secretion and its concentration is diminished in AN patients 
[47]. Vasopressin, alongside its role in water reabsorption, 
is also involved in social behavior and sexual motivation 
[18], and even though its variation in anorexia is yet 
debatable, it also seems to stimulate adrenocorticotropic 
hormone (ACTH), which blunts functioning of the 
reproductive axis [66]. Last, there is controversy regarding 
the effects of oxytocin on anxiety, and while some authors 
report low levels in AN, interfering with empathy and 
attachment mechanisms, others consider it a potent 
anxiogenic factor that limits food intake of anorexic 
females [18,66]. 
Highlights 
✓ Anorexia nervosa leads to functional amenorrhea and 
impaired reproductive function. 
✓ Females with a lifetime diagnosis of anorexia nervosa 
are more likely to seek specialized medical help at 
infertility clinics. 
✓ Pregnancy and birth outcomes of ever-affected women 
is controversial, but in the long term is rather good and 
similar to that within the general population. 
Conclusions 
Women with current AN have an impaired fertility 
status, but those who have recovered generally have, if 
desired and on a long term, a high chance for pregnancy 
and a good birth outcome. There are clear relationships 
between reproductive function and adipose tissue, 
nutritional status, intensity of physical exercises, and 
mental state. Although some of the underlying mechanisms 
for AN and reproductive anomalies are now being 
clarified, many hypotheses remain unexplored. To date, 
clinical trials regarding the dynamics of neurotransmitter 
involvement in the reproductive function of AN women is 
sparse, but a rising interest in the field will likely shed more 
light on the issue. 
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